Autin was introduced to a clinical trial, the first use of potential drugs on human patients, at University Medical Center in ...
Q32 Bio (NASDAQ:QTTB) surged after positive mid-stage alopecia trial data, followed by a stock offering, keeping the ...
Prime Medicine stock analysis: a $548M valuation vs. a best-in-class gene-editing pipeline, key catalysts, M&A upside, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results